دورية أكاديمية
أعرض في EDS

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia.

التفاصيل البيبلوغرافية
العنوان: A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia.
المؤلفون: Biagi M; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Room 164 (M/C 886), Chicago, IL 60612, USA. mbiagi2@uic.edu., Butler D; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Room 164 (M/C 886), Chicago, IL 60612, USA. dbutler1@uic.edu., Tan X; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Room 164 (M/C 886), Chicago, IL 60612, USA. xt9@uic.edu., Qasmieh S; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Room 164 (M/C 886), Chicago, IL 60612, USA. sqasmieh@uic.edu., Wenzler E; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Room 164 (M/C 886), Chicago, IL 60612, USA. wenzler@uic.edu.
المصدر: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2019 Mar 16; Vol. 8 (1). Date of Electronic Publication: 2019 Mar 16.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101637404 Publication Model: Electronic Cited Medium: Print ISSN: 2079-6382 (Print) Linking ISSN: 20796382 NLM ISO Abbreviation: Antibiotics (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, 2012-
مستخلص: Despite advancements in therapy, pneumonia remains the leading cause of death due to infectious diseases. Novel treatment strategies are desperately needed to optimize the antimicrobial therapy of patients suffering from this disease. One such strategy that has recently garnered significant attention is the use of inhaled antibiotics to rapidly achieve therapeutic concentrations directly at the site of infection. In particular, there is significant interest in the role of inhaled polymyxins for the treatment of nosocomial pneumonia, including ventilator-associated pneumonia, due to their retained activity against multi-drug resistant Gram-negative pathogens, including Acinetobacter baumannii and Pseudomonas aeruginosa . This review will provide a comprehensive overview of the pharmacokinetic/pharmacodynamic profile, clinical outcomes, safety, and potential role of inhaled polymyxins in clinical practice.
References: Ann Pharmacother. 1999 Sep;33(9):960-7. (PMID: 10492501)
Pediatrics. 2000 Dec;106(6):E89. (PMID: 11099632)
J Clin Microbiol. 2001 Jan;39(1):183-90. (PMID: 11136768)
Arch Dis Child. 2001 May;84(5):432-3. (PMID: 11316693)
Eur J Pharm Biopharm. 2002 Jul;54(1):25-32. (PMID: 12084499)
J Pharmacol Exp Ther. 2003 Jan;304(1):441-52. (PMID: 12490621)
Am J Respir Cell Mol Biol. 2003 Jul;29(1):62-70. (PMID: 12600828)
Antimicrob Agents Chemother. 2003 Apr;47(4):1364-70. (PMID: 12654671)
Antimicrob Agents Chemother. 1992 Jun;36(6):1171-5. (PMID: 1416816)
J Cyst Fibros. 2004 Mar;3(1):23-8. (PMID: 15463883)
Chest. 2005 Jan;127(1):213-9. (PMID: 15653986)
Am J Health Syst Pharm. 2005 Jan 1;62(1):39-47. (PMID: 15658071)
Crit Care. 2005 Feb;9(1):R53-9. (PMID: 15693967)
Chest. 2005 Feb;127(2):522-9. (PMID: 15705991)
Clin Infect Dis. 2005 May 1;40(9):1333-41. (PMID: 15825037)
Antimicrob Agents Chemother. 2005 Jun;49(6):2429-37. (PMID: 15917543)
Clin Infect Dis. 2005 Sep 1;41(5):754-7. (PMID: 16080101)
Expert Opin Drug Deliv. 2006 Jan;3(1):71-86. (PMID: 16370941)
J Clin Invest. 1975 Mar;55(3):514-9. (PMID: 163848)
J Infect. 2006 Oct;53(4):274-8. (PMID: 16442632)
Crit Care. 2006 Feb;10(1):R27. (PMID: 16507149)
Antimicrob Agents Chemother. 2006 Jun;50(6):1953-8. (PMID: 16723551)
N Engl J Med. 1975 Sep 4;293(10):471-5. (PMID: 168487)
Crit Care. 2006;10(4):R123. (PMID: 16934148)
Eur J Clin Microbiol Infect Dis. 2006 Sep;25(9):596-9. (PMID: 16955249)
Diagn Microbiol Infect Dis. 2007 Jun;58(2):235-40. (PMID: 17350201)
N Engl J Med. 2007 Nov 29;357(22):2310-1. (PMID: 18046039)
Respir Med. 2008 Mar;102(3):407-12. (PMID: 18060758)
Surg Infect (Larchmt). 2008 Apr;9(2):153-60. (PMID: 18426347)
Respir Med. 2009 May;103(5):707-13. (PMID: 19118994)
Clin Infect Dis. 2009 Jun 15;48(12):1724-8. (PMID: 19438394)
Clin Infect Dis. 2009 Jun 15;48(12):1729-31. (PMID: 19438398)
Intensive Care Med. 2009 Oct;35(10):1692-702. (PMID: 19547955)
Clin Microbiol Infect. 2010 Aug;16(8):1230-6. (PMID: 19732088)
Burns. 2010 Jun;36(4):522-7. (PMID: 19864072)
Pharmacotherapy. 2010 Jun;30(6):562-84. (PMID: 20500046)
Antimicrob Agents Chemother. 2010 Sep;54(9):3702-7. (PMID: 20547787)
Chest. 2010 Dec;138(6):1333-9. (PMID: 20558557)
Antimicrob Agents Chemother. 2010 Sep;54(9):3998-9. (PMID: 20585134)
Respir Care. 2010 Jul;55(7):845-51. (PMID: 20587095)
Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S120-5. (PMID: 20597661)
Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S81-7. (PMID: 20597676)
J Microbiol Immunol Infect. 2010 Aug;43(4):323-31. (PMID: 20688293)
J Antimicrob Chemother. 2010 Dec;65(12):2645-9. (PMID: 20876621)
Clin Infect Dis. 2010 Dec 1;51(11):1238-44. (PMID: 20973727)
Pharmacotherapy. 2011 Feb;31(2):146-57. (PMID: 21275493)
Med Intensiva. 2011 May;35(4):226-31. (PMID: 21396739)
Clin Infect Dis. 2011 May;52(10):1278-9; author reply 1279-80. (PMID: 21507926)
Clin Pharmacol Ther. 2011 Jun;89(6):875-9. (PMID: 21544080)
Antimicrob Agents Chemother. 2011 Jul;55(7):3284-94. (PMID: 21555763)
Clin Infect Dis. 2011 Jun 15;52(12):1472-3; author reply 1473-4. (PMID: 21628491)
J Antimicrob Chemother. 2011 Sep;66(9):2070-4. (PMID: 21715434)
Crit Care Med. 2011 Dec;39(12):2736-42. (PMID: 21765351)
Clin Infect Dis. 2011 Nov;53(9):879-84. (PMID: 21900484)
Clin Pharmacokinet. 2011 Nov 1;50(11):689-704. (PMID: 21973267)
Clin Microbiol Infect. 2012 Sep;18(9):870-6. (PMID: 21999321)
BMC Infect Dis. 2011 Nov 15;11:317. (PMID: 22085766)
Physiol Rev. 2012 Jan;92(1):367-520. (PMID: 22298659)
Infect Control Hosp Epidemiol. 2012 Mar;33(3):250-6. (PMID: 22314062)
J Infect Chemother. 2012 Dec;18(6):872-7. (PMID: 22644081)
Antimicrob Agents Chemother. 2012 Sep;56(9):4625-9. (PMID: 22687519)
Intensive Care Med. 2012 Nov;38(11):1779-86. (PMID: 22810779)
J Antimicrob Chemother. 2012 Dec;67(12):2793-803. (PMID: 22915465)
Curr Opin Infect Dis. 2012 Dec;25(6):626-33. (PMID: 23041772)
Anesthesiology. 2012 Dec;117(6):1335-47. (PMID: 23132092)
J Infect. 2013 May;66(5):401-14. (PMID: 23142195)
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14. (PMID: 23221186)
Pediatr Pulmonol. 2014 Apr;49(4):381-8. (PMID: 23359527)
Lancet Infect Dis. 2013 Aug;13(8):665-71. (PMID: 23622939)
Clin Infect Dis. 2013 Aug;57(4):524-31. (PMID: 23697744)
Crit Care Med. 2013 Sep;41(9):2151-61. (PMID: 23760154)
Antimicrob Agents Chemother. 2013 Oct;57(10):5087-95. (PMID: 23917323)
BMC Infect Dis. 2013 Aug 19;13:380. (PMID: 23957376)
Chest. 2013 Dec;144(6):1768-1775. (PMID: 23989805)
J Antimicrob Chemother. 2014 Jan;69(1):275-7. (PMID: 23997018)
Am J Infect Control. 2014 Jan;42(1):38-42. (PMID: 24199911)
BMC Anesthesiol. 2013 Nov 25;13(1):45. (PMID: 24274315)
Yonsei Med J. 2014 Jan;55(1):118-25. (PMID: 24339296)
Antimicrob Agents Chemother. 2014 May;58(5):2570-9. (PMID: 24550334)
Antimicrob Agents Chemother. 2014 May;58(5):2740-6. (PMID: 24566187)
N Engl J Med. 2014 Mar 27;370(13):1198-208. (PMID: 24670166)
Antimicrob Agents Chemother. 2014 Jul;58(7):3950-6. (PMID: 24798284)
Antimicrob Agents Chemother. 2014 Nov;58(11):6946-8. (PMID: 25136012)
Biomed J. 2014 Sep-Oct;37(5):314-20. (PMID: 25179700)
Antimicrob Agents Chemother. 2014 Dec;58(12):7331-9. (PMID: 25267660)
J Microbiol Immunol Infect. 2016 Aug;49(4):523-30. (PMID: 25442877)
Am J Infect Control. 1989 Jun;17(3):121-5. (PMID: 2545119)
Crit Care Med. 2015 Mar;43(3):527-33. (PMID: 25493971)
Pharmacotherapy. 2015 Jan;35(1):34-42. (PMID: 25630411)
Pharm Res. 2015 Oct;32(10):3403-14. (PMID: 26040660)
Respir Care. 2015 Jun;60(6):762-1; discussion 771-3. (PMID: 26070573)
Intensive Care Med. 2015 Aug;41(8):1411-23. (PMID: 26162677)
Expert Opin Drug Saf. 2015;14(11):1687-701. (PMID: 26365594)
Eur Respir J. 2015 Dec;46(6):1732-9. (PMID: 26405294)
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2443-9. (PMID: 26856846)
Ann Clin Microbiol Antimicrob. 2016 Feb 24;15:11. (PMID: 26911714)
Ann Intensive Care. 2016 Dec;6(1):26. (PMID: 27033711)
Crit Care Med. 2016 May;44(5):e304. (PMID: 27083024)
Chest. 2016 Nov;150(5):1008-1014. (PMID: 27102181)
Clin Microbiol Rev. 2016 Jul;29(3):581-632. (PMID: 27226088)
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. (PMID: 27418577)
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1845-1850. (PMID: 27510182)
Int J Antimicrob Agents. 2017 Feb;49(2):233-238. (PMID: 27686609)
Antimicrob Agents Chemother. 2016 Dec 27;61(1):. (PMID: 27821445)
Antimicrob Agents Chemother. 2017 Feb 23;61(3):. (PMID: 27993859)
Antimicrob Agents Chemother. 2017 Mar 24;61(4):. (PMID: 28069649)
Antimicrob Agents Chemother. 2017 May 24;61(6):. (PMID: 28416543)
J Thorac Dis. 2017 Mar;9(3):555-567. (PMID: 28449463)
J Crit Care. 2017 Aug;40:251-256. (PMID: 28458172)
Antimicrob Agents Chemother. 2017 Jun 27;61(7):. (PMID: 28483953)
Antimicrob Agents Chemother. 2017 Jul 25;61(8):. (PMID: 28559256)
Int J Antimicrob Agents. 2018 Jan;51(1):1-9. (PMID: 28669836)
Antimicrob Agents Chemother. 2017 Oct 24;61(11):. (PMID: 28807905)
Am J Infect Control. 2018 Mar;46(3):322-327. (PMID: 29050905)
Lancet Infect Dis. 2018 Mar;18(3):318-327. (PMID: 29276051)
Int J Antimicrob Agents. 2018 May;51(5):700-706. (PMID: 29305954)
Expert Opin Pharmacother. 2018 Mar;19(4):397-408. (PMID: 29411661)
Curr Infect Dis Rep. 2018 Mar 6;20(2):3. (PMID: 29511909)
Natl Vital Stat Rep. 2018 Jul;67(6):1-77. (PMID: 30248017)
Medicine (Baltimore). 2018 Sep;97(39):e12278. (PMID: 30278498)
Clin Chest Med. 2018 Dec;39(4):853-869. (PMID: 30390754)
Pharmacotherapy. 2019 Jan;39(1):10-39. (PMID: 30710469)
Ann Intern Med. 1971 Jan;74(1):144-5. (PMID: 4321710)
J Clin Invest. 1973 Nov;52(11):2935-40. (PMID: 4356004)
Ann Intern Med. 1970 Jun;72(6):857-68. (PMID: 5448745)
Chest. 1981 Feb;79(2):237-9. (PMID: 6257452)
Am J Med. 1984 Nov;77(5):834-8. (PMID: 6496537)
Intensive Care Med. 1994;20(3):187-92. (PMID: 8014284)
Thorax. 1997 Jul;52(7):656-8. (PMID: 9246141)
Biochem J. 1979 Sep 1;181(3):623-32. (PMID: 92986)
فهرسة مساهمة: Keywords: HAP; VAP; colistin; inhaled antibiotics; pneumonia; polymyxin
تواريخ الأحداث: Date Created: 20190320 Latest Revision: 20201001
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC6466860
DOI: 10.3390/antibiotics8010027
PMID: 30884839
قاعدة البيانات: MEDLINE
الوصف
تدمد:2079-6382
DOI:10.3390/antibiotics8010027